文献速递中医内科中药与中成药合理使用

复方鸡血草汤改善慢性肾衰竭内质网应激与凋亡的网络分析与实验验证

Integrated network analysis and experimental verification of the mechanisms employed by Compound Jixuecao Decoction to improve endoplasmic reticulum stress and apoptosis in chronic renal failure.
PubMed 文献 · J Ethnopharmacol · 2024-02-28

该研究采用网络药理学、分子对接、分子动力学模拟及5/6肾切除大鼠模型,探讨复方鸡血草汤治疗慢性肾衰竭的内质网应激与凋亡机制。结果显示该方剂主要靶向MFN2、BCL2、BAX、PERK和CHOP,体内实验证实其可上调MFN2和BCL2、下调BAX、PERK和CHOP蛋白丰度。结论提示该方通过调节MFN2及PERK-eIF2α-ATF4-CHOP信号通路延缓慢性肾衰竭。

要点

  • 复方鸡血草汤可能通过调控MFN2及PERK-eIF2α-ATF4-CHOP通路改善慢性肾衰竭。
  • 网络药理学预测该方剂关键靶点包括MFN2、BCL2、BAX、PERK和CHOP。
  • 5/6肾切除大鼠模型验证该方剂可上调MFN2、BCL2并下调BAX、PERK、CHOP。

核心结论

  • 复方鸡血草汤通过调节MFN2和PERK-eIF2α-ATF4-CHOP信号通路有效延缓慢性肾衰竭。

研究设计与样本

  • 研究采用网络药理学、分子对接、分子动力学模拟及5/6肾切除大鼠模型进行体内验证。
  • 从TCMSP数据库提取复方鸡血草汤成分,共鉴定80种化合物,对应875个靶基因,其中216个与慢性肾衰竭潜在相关。

主要发现

  • PPI网络分析通过拓扑过滤揭示关键靶点,富集分析、分子对接和分子动力学模拟提示该方主要靶向MFN2、BCL2、BAX、PERK和CHOP。
  • 体内实验显示复方鸡血草汤显著增加肾脏组织中MFN2和BCL2蛋白丰度,并显著降低BAX、PERK和CHOP蛋白丰度。

临床怎么用

  • 该研究为复方鸡血草汤治疗慢性肾衰竭提供了内质网应激与凋亡调控方面的机制证据,可供中医及中西医结合临床参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Compound Jixuecao Decoction (CJD) is a traditional Chinese herbal medicine prescribed in China to treat chronic renal failure (CRF). Previous studies have shown that CJD affects cell apoptosis and proliferation. However, the mechanism of its renal protective action has not been characterized. AIM OF THE STUDY: To explore the mechanism(s) underlying the effect of CJD on endoplasmic reticulum stress (ERS) and apoptosis in the treatment of CRF using network pharmacology, molecular docking, molecular dynamics simulations, and in vivo studies. MATERIALS AND METHODS: The compounds comprising CJD were extracted from the Traditional Chinese Medicine Systems Pharmacology Database. A Swiss target prediction database and similarity integration approach were employed to identify potential targets of these components. The GeneCards and DisGeNET databases were used to identify targets associated with CRF, apoptosis, and ERS. The STRING database was employed to analyze the protein-protein interactions (PPIs) associated with drug-disease crossover. A chemical composition-shared target network was established, and critical pathways were identified through gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses. The Protein Data Bank database was used to search key proteins, while molecular docking and dynamics simulations were performed between the top four CJD active ingredients and proteins involved in apoptosis and ERS in CRF. Subsequent in vivo studies using a 5/6 nephrectomy rat model of CRF were performed to verify the findings. RESULTS: The 80 compounds identified in CJD yielded 875 target genes, of which 216 were potentially related to CRF. PPI network analysis revealed key targets via topology filtering. Enrichment analysis, molecular docking, and molecular dynamics simulation results suggested that CJD primarily targets mitofusin-2 (MFN2), B-cell lymphoma-2 (BCL2), BAX, protein kinase RNA-like ER kinase (PERK), and C/EBP homologous protein (CHOP) during CRF treatment. In vivo, CJD significantly increased the abundance of MFN2, BCL2, and significantly reduced the abundance of BAX, PERK, CHOP proteins in kidney tissues, indicating that CJD could improve apoptosis and ERS in CRF rats. CONCLUSIONS: This study provides evidence that CJD effectively delays CFR through modulation of the MFN2 and PERK-eIF2α-ATF4-CHOP signaling pathways.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zheng H, Zeng J, Bi P, et al. Integrated network analysis and experimental verification of the mechanisms employed by Compound Jixuecao Decoction to improve endoplasmic reticulum stress and apoptosis in chronic renal failure. J Ethnopharmacol. 2024. PMID: 38423413. doi:10.1016/j.jep.2024.117959

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。